Procedure:   in vitro assay          


    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Cowell1 49002 in vitro assay Staphylococcus aureus log10 bacterial colony count from peritoneal fluid 24h post-infection (x 103) (CFU/mL)   [log(n/mL)]  peritoneal_CFU inbred 13 f 8wks N=5 2012
    Cowell1 49003 in vitro assay Staphylococcus aureus log10 bacterial colony count from kidney 24h post-infection (CFU/g)   [log(n/g)]  kidney_CFU inbred 13 f 8wks N=6 2012
    Dietrich1 1501 in vitro assay Bacillus anthracis lethal toxin susceptibility to Bacillus anthracis   [designation]  anthrax_lethal_toxin inbred 50 f 6-8wks* 1998
    Ferris1 47606 in vitro assay influenza A (H1N1) virus viral replication log titer, day 4 post-infection (lung)   [n]  titer CC pre w/CC8 162 f 8-16wks N=1 2012
    Gros1 38501 in vitro assay Candida albicans kidney fungal load 48h post-infection,
colony-forming units (log10 CFU per kidney)   [log(n)]
 fungal_load
inbred 23 f 8-12wks N=9 2011
    Gros1 38502 in vitro assay Candida albicans susceptibility to C. albicans based on fungal load
(0=susceptible; 1=resistant)   [designation]
 susceptibility
inbred 23 f 8-12wks N=9 2011
Rodriguez1 24101 in vitro assay (none) spleen and liver murine cytomegalovirus genome levels   [PFU]  CMV_LEVELS QTL population both 8-12wks N=92 2009
    Schughart4 58783 in vitro assay influenza A (H3N2) virus viral load in lungs (titer, FFU per lung) log10 (x+1), treated group   [log(n)]     days post-infection:    3    5    8 inbred w/CC8 8 f 8-12wks N=5 2016
    All boxes